PUBLIC COMPANY
save$ZLABZai Lab Ltd
$ZLAB25.50-3.19%Shanghai, CNupdated 19h ago
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Preclinical1Phase 11Phase 3
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Insider activity
source: SEC Form 4🐶 Hiring Signal
next earnings Nov 5, 2026
News
- Merck, Daiichi end plans to seek speedy approval of lung cancer ADCThe FDA indicated that the data generated so far wouldn’t support an accelerated clearance of “I-DXd,” a setback that erases an edge Merck and Daiichi had over multiple fast-moving competitors.biopharma_dive · 4d ago
Data sources
last refreshed 42m ago
Found something off?
comments(0)
5-min edit window · permanent after that